Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage.

Source:http://linkedlifedata.com/resource/pubmed/id/19968611

Download in:

View as

General Info

PMID
19968611